零零客微文大全00ke.net

  • 倒计时3天,药明康德2021年一季度业绩交流电话会(附电话会议拨入信息)|Bil
  • 来源:药明康德

尊敬的投资者,

 

我们诚挚邀请您参加药明康德2021年一季度业绩交流电话会,出席会议请拨打下图电话号码。

  • 中文会议将于北京时间2021年4月30日上午9:00-10:00召开

  • 英文会议将于北京时间2021年4月30日上午8:00-8:55召开


图片


Dear Investors,


WuXi AppTec is pleased to invite you to our 1Q 2021 Earnings Call. We thank you for your interest and we sincerely hope you will join us.

  • English Earnings Call at 8:00-8:55 a.m., April 30, China time (8:00-8:55 p.m., April 29, 2021, EST)

  • Chinese Earnings Call at 9:00-10:00 a.m., April 30, China time


图片


关于药明康德
药明康德(股票代码:603259.SH/2359.HK)为全球生物医药行业提供全方位、一体化的新药研发和生产服务。通过赋能全球制药、生物科技和医疗器械公司,药明康德致力于推动新药研发进程,为患者带来突破性的治疗方案。本着以研究为首任,以客户为中心的宗旨,药明康德通过高性价比和高效的研发服务,助力客户提升研发效率,服务范围涵盖化学药研发和生产、细胞及基因疗法研发生产、医疗器械测试等领域。目前,药明康德的赋能平台正承载着来自全球30多个国家的4400多家合作伙伴的研发创新项目,致力于将更多新药、好药带给全球病患,早日实现“让天下没有难做的药,难治的病”的愿景。

About WuXi AppTec
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient, socially responsible and sustainable solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 4,400 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated."


图片

健康

1 2 3 4 5 >> 

公众号 • 药明康德

  • 药明康德微信号 : WuXiAppTecChina
  • 全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台,帮助任何人、任何公司更快、更好地研发新医药产品,探索无限可能
  • 手机微信扫描上方二维码进行订阅
Flag Counter